CORTI, Angelo

CORTI, Angelo  

Mostra records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autore(i) File
A new predictive sensor for the doxorubicin-dependent cardiotoxicity: The paradigm of chromogranin-A 1-gen-2020 Rocca, C.; Granieri, M. C.; Colombo, B.; Gasparri, A. M.; Dallatomasina, A.; Pasqua, T.; De Bartolo, A.; Scavello, F.; Amelio, D.; Cerra, M. C.; Tota, B.; Corti, A.; Angelone, T.
Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells 1-gen-2019 Sahu, B. S.; Mahata, S.; Bandyopadhyay, K.; Mahata, M.; Avolio, E.; Pasqua, T.; Sahu, C.; Bandyopadhyay, G. K.; Bartolomucci, A.; Webster, N. J. G.; Van Den Bogaart, G.; Fischer-Colbrie, R.; Corti, A.; Eiden, L. E.; Mahata, S. K.
Muscle injury, impaired muscle function and insulin resistance in Chromogranin a-knockout mice 1-gen-2017 Tang, K; Pasqua, T; Biswas, A; Mahata, S; Tang, J; Tang, A; Bandyopadhyay, Gk; Sinha-Hikim, Ap; Chi, Nw; Webster, Nj; Corti, A; Mahata, Sk
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity 1-gen-2019 Rocca, Carmine; Scavello, Francesco; Colombo, Barbara; Gasparri, Anna Maria; Dallatomasina, Alice; Granieri, Maria Concetta; Amelio, Daniela; Pasqua, Teresa; Cerra, Maria Carmela; Tota, Bruno; Corti, Angelo; Angelone, Tommaso
“Chromogranin A and uses thereof" Chromogranin A protects from doxorubicin-induced cardiotoxicity 1-gen-2018 Angelone, Tommaso; Tota, B.; Corti, Angelo